Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer

International Journal of Urology

Volumn 19, Issue 11, 2012, Pages 988-993

  Lightfoot, Andrew J ^a   Rosevear, Henry M ^a   Nepple, Kenneth G ^a   O'Donnell, Michael A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Biopsy; Bladder neoplasms; Cystoscopy; Cytology; Neoplasm staging

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CATHETERIZATION; BLADDER RUPTURE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER STAGING; CYSTOSCOPY; FEMALE; HEART INFARCTION SIZE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; PROSTATE BIOPSY; URINARY TRACT BIOPSY; URINE CYTOLOGY;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CYSTOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URETHRA; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84868204723     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2012.03089.x     Document Type: Article

References (16)

1. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur. Urol. 2008; 54: 303-14.
2. Hall MC, Chang SS, Dalbagni G etal. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J. Urol. 2007; 178: 2314-30.
3. Lamm DL, Blumenstein BA, Crissman JD etal. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J. Urol. 2000; 163: 1124-9.
4. Highshaw RA, Tanaka ST, Evans CP, deVere White RW. Is bladder biopsy necessary at three or six months post BCG therapy? Urol. Oncol. 2003; 21: 207-9.
5. Skemp NM, Fernandes ET. Routine bladder biopsy after bacille Calmette-Guerin treatment: is it necessary? Urology 2002; 59: 224-6.
6. Guy L, Savareux L, Molinie V, Botto H, Boiteux JP, Lebret T. Should bladder biopsies be performed routinely after bacillus Calmette-Guerin treatment for high-risk superficial transitional cell cancer of the bladder? Eur. Urol. 2006; 50: 516-20; discussion 520.
7. Dalbagni G, Rechtschaffen T, Herr HW. Is transurethral biopsy of the bladder necessary after 3months to evaluate response to bacillus Calmette-Guerin therapy? J. Urol. 1999; 162: 708-9.
8. Murakami T, Ebara S, Saika T etal. Routine transurethral biopsy of the bladder is not necessary to evaluate the response to bacillus calmette-guerin therapy. Acta Med. Okayama 2007; 61: 341-4.
9. Nepple KG, Joudi FN, O'Donnell MA. Review of topical treatment of upper tract urothelial carcinoma. Adv. Urol. 2009; 2009: Article ID 472831.
10. Hara T, Takahashi M, Gondo T etal. Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy. Int. J. Urol. 2009; 16: 192-5.
11. May F, Treiber U, Hartung R, Schwaibold H. Significance of random bladder biopsies in superficial bladder cancer. Eur. Urol. 2003; 44: 47-50.
12. van der Meijden A, Oosterlinck W, Brausi M, Kurth KH, Sylvester R, de Balincourt C. Significance of bladder biopsies in Ta, T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur. Urol. 1999; 35: 267-71.
13. Solsona E, Iborra I, Ricos JV, Dumont R, Casanova JL, Calabuig C. Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management. Urology 1997; 49: 347-52.
14. Witjes JA. Bladder carcinoma in situ in 2003: state of the art. Eur. Urol. 2004; 45: 142-6.
15. O'Donnell MA, Boehle A. Treatment options for BCG failures. World J. Urol. 2006; 24: 481-7.
16. Witjes JA, Kiemeney LA, Schaafsma HE, Debruyn FM. The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group. Br. J. Urol. 1994; 73: 172-6.